<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA101489-0163</title>
	</head>
	<body>
		<main>
			<p><P> October 14, 1989, Saturday, Orange County Edition  </P> <P> EARNINGS  </P> <P> ICN Pharmaceuticals Inc. said a loss recorded by its Viratek subsidiary  resulted in a net loss of $2.1 million for the third quarter. The company  posted net income of $7.1 million for the comparable quarter in 1988. Sales  rose 2%, to $42.6 million from $41.7 million.  </P> <P> For the nine-month period, the Costa Mesa-based company reported net income of  $3.8 million, compared to net income of $17.2 million in 1988. Sales increased  10%, to $129.6 million from $117.4 million.  </P> <P> ICN said that while its pharmaceutical marketing and biomedical subsidiaries  turned in strong results in the quarter, they were offset by a net loss  reported by Viratek, its pharmaceutical research and development subsidiary.  </P> <P> ICN Pharmaceuticals makes pharmaceutical and biomedical products.  </P></p>
		</main>
</body></html>
            